If a large new production facility runs on renewable energy, the carbon footprint of cultivated meat would be lower than conventional beef, pork, and chicken. The analysis calculates that the footprint is roughly 92% lower than beef, 52% lower than pork, and 17% lower than chicken, even if the conventional meat is produced in ways that are more sustainable than what’s standard now—for example, changing feed so cattle burp less methane, a potent greenhouse gas.
Dutch cultured meat startup Meatable announced today that it has raised a $47 million Series A round of funding. Investors include Dr. Rick Klausner, Section 32, Dr. Jeffrey Leiden, and DSM Venturing, with participation from existing investors including BlueYard Capital, Agronomics, Humboldt, and Taavet Hinrikus. This brings Meatable’s total funding raised so far to $60 million.
Bluu Biosciences has raised €7 million in a round of financing from investors including Manta Ray Ventures, Norrsken VC, Be8, CPT Capital and Lever VC to compete with a host of startups like BluNalu, Wild Type and Shiok Meats in a bid to market with a lab-grown fish replacement.
The company is picking up speed quickly thanks to those other technology providers that are coming to market and will look to have a prototype product out by the end of 2022.
Companies developing sustainable meat and dairy alternatives smashed records with a €2.6B ($3.1B) haul last year. Why has it been such a bumper harvest?
In spite of the financial chaos resulting from the Covid-19 pandemic over the last 12 months, a staggering €2.6B ($3.1B) in funding went to companies in the meat and dairy alternatives sector, according to the nonprofit the Good Food Institute (GFI). This tripled 2019’s total.
Developers of plant-based alternatives reaped the lion’s share with €1.8B ($2.1B); biotechs producing protein via fermentation took a neat €497M ($590M); and more than €303M ($360M) backed companies developing cultured meat.
“Using techniques developed for regenerative medicine, we succeeded in culturing millimeter-sized chunks of meat wherein alignment of the myotubes help mimic the texture and mouthfeel of steak. For this, myoblasts drawn from commercial beef were cultured in hydrogel modules that could be stacked allowing fusion into larger chunks. We determined the optimal scaffolding and electrical stimulation to promote contractility and anatomical alignment of the muscle tissue to best simulate steak meat.”
The interest for artificial meat has recently expanded. However, from the literature, perception of artificial meat in China is not well known. A survey was thus carried out to investigate Chinese attitudes toward artificial meat. The answers of 4666 respondents concluded that 19.9% and 9.6% of them were definitely willing and unwilling to try artificial meat respectively, whereas 47.2% were not willing to eat it regularly, and 87.2% were willing to pay less for it compared to conventional meat. Finally, 52.9% of them will accept artificial meat as an alternative to conventional meat.
VitroLabs Inc seeks a reliable, highly-motivated and exceptionally innovative tissue engineer to lead a team on the development of novel bioreactor systems to support industrial-scale production of new in vitro-grown animal tissues for leather applications. The ideal candidate for this role is no stranger to thinking “outside the box” whether they are conducting an experiment in the lab or developing a new process.
The New Food Invest is a 3-in-1 conference format, catering for three different time zones on a single day: it provides convenient access for the Asian/Australian market followed by the European/Middle Eastern region and closes with a focus on the North & South American continent. Each NFI ticket grants access to all sessions and leverages the value of the event, providing you with 12 hours of attractive programming.
Source: New Food Invest
So why is it that women are particularly well-represented in Asian plant-based and cultivated meat companies, compared with other industries and regions? We spoke to some of the brilliant CEOs, scientists, investors, and innovators who have helped transition the region’s alternative protein space from a nascent niche into a global economic engine in just a handful of years, to get insights into how (and why) they made. it. happen.
In this prospective Life Cycle Assessment (LCA) study of cultivated meat (CM, also sometimes referred to as cell-based meat, clean meat, cultured meat and in-vitro meat) we provide insight into the environmental impact of this product when produced at commercial scales. This is the first LCA study to use primary data from multiple CM producers and companies in the upstream supply chain. Data collection efforts were carried out among over 15 companies active in CM development and the supply chain, supplemented with cross-checks by independent experts. While there are still uncertainties due to the early stage of technological development, we believe this study provides a robust inventory with as much primary data as is currently feasible.